🟠 Moderate Evidence
Zinc supplementation above 50 mg daily triggers copper depletion through a well-characterised intestinal mechanism that resists simple dietary compensation, according to controlled trials published in the American Journal of Clinical Nutrition. The mechanism involves zinc-induced production of metallothionein, a protein that preferentially traps copper inside intestinal cells, which are then shed and lost in faeces.
Key takeaways
- Zinc supplementation at 50 mg daily depleted copper-dependent enzyme function by 47% in healthy women within 10 weeks, detected by functional markers but not standard serum tests
- Metallothionein, a zinc-induced intestinal protein, binds copper with higher affinity than zinc and remains present even when zinc intake stops, trapping copper in cells that are naturally shed
- Additional oral copper supplementation does not reliably overcome zinc-induced copper depletion while high zinc doses persist, making the mechanism clinically significant for long-term supplementation users
Study at a Glance
| Source | American Journal of Clinical Nutrition |
| Study type | Controlled trial |
| Sample size | N = 18 healthy women (Yadrick et al.); N = 13 healthy men (Fischer et al.) |
| Population | Healthy adults with normal diets |
| Intervention | 50 mg zinc gluconate daily for 6–10 weeks |
| Country | United States |
Copper Depletion Response to Zinc Supplementation
Functional enzyme markers show copper depletion that standard serum tests miss, United States, 1984–1989
Source: Yadrick et al., 1989; Fischer et al., 1984, American Journal of Clinical Nutrition | Georgian Medical Journal News
Zinc Triggers Copper-Trapping Protein in the Gut
When zinc enters the intestine at supplemental doses, epithelial cells lining the gut respond by producing metallothionein, a metal-binding protein with selective affinity for copper. The mechanism is not simply competitive—metallothionein preferentially captures copper over zinc, even though zinc triggered its production. This creates a paradox: the supplement meant to boost one micronutrient inadvertently creates a copper trap.
Intestinal epithelial cells naturally turn over every 3 to 5 days, and when they slough into the faecal stream, they carry their trapped copper with them. The result is cumulative copper loss through a route that standard dietary measures cannot easily correct. This process is independent of copper intake and continues as long as zinc supplementation persists.
Standard Tests Miss the Depletion
A critical finding in research by Yadrick and colleagues at the American Journal of Clinical Nutrition (1989) was that serum ceruloplasmin—the standard clinical copper marker—did not change significantly in their trial of 18 healthy women taking 50 mg zinc daily for 10 weeks. Yet erythrocyte superoxide dismutase (ESOD), a copper-dependent enzyme and sensitive functional marker of copper status, declined by 47% (p<0.05).
This discrepancy reveals a clinical blind spot: routine serum copper or ceruloplasmin tests may appear normal even as functional copper deficiency develops. Clinicians relying on conventional serum panels could miss early depletion, particularly in patients on chronic high-dose zinc for immune support or other indications.
Oral Copper Compensation Does Not Reliably Overcome the Mechanism
The persistence of zinc-induced metallothionein creates a therapeutic challenge: simply adding more copper to the diet does not reliably reverse the depletion while high zinc doses remain active. The protein induced by zinc continues to trap copper inside intestinal cells, preventing adequate absorption regardless of dietary or supplemental copper intake.
This mechanism is so consistent and well-characterised that zinc is actually FDA-approved as a therapeutic treatment for Wilson’s disease, a genetic copper overload disorder. At therapeutic zinc doses (typically 25–50 mg daily), zinc-induced copper depletion is the intended clinical effect. However, for individuals taking zinc for immune support or other non-therapeutic reasons, the risk of copper depletion—and its potential consequences—may not be widely appreciated.
Erythrocyte superoxide dismutase activity, a copper-dependent enzyme and one of the most sensitive functional markers of copper status, declined 47% within 10 weeks of 50 mg daily zinc supplementation in healthy women, despite normal serum ceruloplasmin levels.
— Yadrick et al., American Journal of Clinical Nutrition (1989)
What this means
Frequently asked questions
Is 50 mg of zinc per day a high dose?
No—50 mg is a common over-the-counter supplement dose, not a megadose. The recommended dietary allowance (RDA) for zinc is 8–11 mg daily, so 50 mg represents a 5–6 fold excess. This level is widely available in cold-season immune support formulations and is considered a standard supplemental intake by many manufacturers, yet it is sufficient to trigger measurable copper depletion within weeks according to controlled trials by Yadrick et al. and Fischer et al. in the American Journal of Clinical Nutrition.
How long does zinc-induced copper depletion take to develop?
Functional copper depletion (measured by erythrocyte superoxide dismutase decline) can develop within 6–10 weeks at 50 mg zinc daily, according to both the Yadrick (1989) and Fischer (1984) trials. However, standard serum copper tests may remain normal throughout this period, making early detection difficult without sensitive functional markers. Copper losses accumulate through the natural 3–5 day turnover of intestinal epithelial cells.
Can increasing dietary copper prevent zinc-induced depletion?
Not reliably, according to the mechanism described by Yadrick et al. The metallothionein protein induced by zinc preferentially traps copper inside intestinal cells before they are shed and lost in faeces. This occurs regardless of dietary copper intake. While oral copper supplementation is theoretically possible, it does not consistently overcome zinc-induced depletion as long as high zinc doses persist, making dose reduction or cessation the more effective strategy.
As zinc supplementation becomes increasingly popular for immune support and other health claims, awareness of this counter-intuitive mechanism becomes clinically relevant. The discovery that a common supplement inadvertently creates a copper trap—one that resists simple dietary fixes—underscores the importance of evidence-based dosing guidance and functional micronutrient monitoring in long-term supplement users. Healthcare systems should consider updating clinical assessment protocols to include sensitive copper status markers alongside routine serum panels.
Source: Yadrick et al., American Journal of Clinical Nutrition, 1989; Fischer et al., American Journal of Clinical Nutrition, 1984
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
